Veru Inc. shares were climbing rapidly in the early hours of trading Wednesday, up more than 16% after the company announced the publication of positive Phase III results from its COVID-19 antiviral therapeutic that could lead to potential Emergency Use Authorization.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,